Discover trends, market shifts, and competitive outlooks for the blood plasma derivatives industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Blood Plasma Derivatives Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The scale of the blood plasma derivatives market has seen significant expansion in the past few years. There’s a prediction of the market value increasing from $51.81 billion in 2024 to $56.24 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.6%. Factors such as the growing occurrence of hemophilia and other bleeding disorders, surge in the number of elderly people, heightened awareness and diagnosis, increase in surgical procedures, and worldwide blood transfusion services have contributed to the growth during the historic period.

The market size for blood plasma derivatives is anticipated to experience significant expansion in the coming years. The market is set to balloon to $80.42 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. The forecasted period growth is due to the rise in therapies for rare diseases, increase in chronic diseases, rise in healthcare expenditure, treatment approaches focused on patients, and the expansion of the healthcare infrastructure. The upcoming period will witness trends such as advancements in fractionation technologies, patient-oriented strategies, alliances and partnerships, growing usage in the field of neurology, and technological breakthroughs in plasma fractionation.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

What are the Fundamental Drivers and Innovations Shaping the Blood Plasma Derivatives Market?

The escalating incidence of immunodeficiency disorders is anticipated to catalyze the expansion of the blood plasma derivatives market. Diseases that partly or wholly compromise the body’s defense mechanism are referred to as immunodeficiency disorders. Blood plasma derivatives are used in the treatment of various medical conditions, including immune deficiency disorders. Plasma, a substance fluid made up of proteins and salts, is made up of over a hundred different proteins, and immunoglobulins are primarily employed to tackle primary immunodeficiencies. Insufficient nutrition or malnourishment can result in deficiencies in macro and micronutrients, which can, in turn, lead to immunodeficiency. For instance, as per the Allergy, Asthma & Clinical Immunology’s March 2022 report, Common Variable Immunodeficiency (CVID) was the most prevalent disorder, affecting 16.6% of individuals in the US, 12.9% internationally, and 13.9% worldwide. Consequently, the rising incidence of immune deficiency disorders is fuelling the expansion of the blood plasma derivatives market.

How Is the Blood Plasma Derivatives Market Segmented?

The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin, Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12107&type=smp

Which Regions Are Driving the Next Phase of the Blood Plasma Derivatives Market Growth?

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Blood Plasma Derivatives Market?

Key players in the blood plasma derivatives market, such as Kedrion S.p.A., a biopharmaceutical firm from Italy, are forming strategic alliances to gain an upper hand. Through these collaborations, a constant and reliable supply of essential plasma-derived medications will become accessible to patients, addressing the growing demand for immunoglobulins not only in France but elsewhere. For example, in January 2022, Kedrion S.p.A. teamed up with a UK firm, LPB, known for biological medicinal products. Immunoglobulins will be produced in Hungary using LFB plasma collected in France by the Etablissement Français du Sang (EFS). This additional supply, obtained from LFB in France, will fortify the current availability of immunoglobulins at hospitals nationally, overseen by French health regulators.

View the full report here:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

How Is the Blood Plasma Derivatives Market Defined and What Are Its Core Parameters?

Blood plasma derivatives are medicinal products crafted from refined proteins found in blood plasma, encompassing clotting factors, albumins, and other proteins employed to treat diverse medical ailments. These derivatives hold significant significance as they aid in replenishing absent or inadequate proteins within the body.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12107

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model